No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Instruments & Supplies
Hogy Medical Co.,Ltd., along with its associated companies, is dedicated to providing medical provisions to healthcare institutions throughout Japan. Their product portfolio encompasses all-inclusive surgical kit solutions designed for pre-operative, intra-operative, and post-operative stages. They also manufacture a variety of non-woven items, such as surgical gowns, personal protective equipment, patient attire, drapes, pre-packaged goods, covers for instrument tables, and wraps. A unique offering is Tigalyer, a specialized multi-layer fabric. For effective sterilization, the company produces hybrid Mekkin bags, including an ID-layered variant, along with autoclave forceps stand caps. Furthermore, Hogy Medical offers Mekkin cards and ethylene oxide gas cards, both crucial for verifying the sterilization process in autoclaves and using ethylene oxide gas, respectively, complemented by indicator tapes for autoclave sterilization. On the technology front, they provide an ME equipment operation management system and an automated system leveraging radio frequency identification (RFID) to manage controlled medications and hazardous substances. Another innovative product is Securea, a polyurethane sponge specifically engineered for endoscopic surgical procedures. Founded in Tokyo, Japan, in 1955, the company operated as Hogy Co., Ltd. until 1987, when it officially changed its name to Hogy Medical Co.,Ltd.
www.hogy.co.jpNo one on the platform currently holds 3593.T.
No tracked institution reports a position in 3593.T as of their last filing.
No one on the platform has traded 3593.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 2.7% | 4.8% | 5.3% | — | — | — |
| Rev. Growth % | 0.1% | 1.0% | ||||
| Profit Margin % | 3.9% | 9.5% | 12.5% | |||
| Free Cash Flow Margin % | 16.7% | 12.4% | 8.4% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $38.7B | +1.0% | $143.80 | $143.80–$143.80 | — | 1 |
| 2028 | $39.4B | +1.8% | $153.50 | $128.58–$178.42 | — | 2 |
| 2029 | $42.1B | +6.9% | $172.50 | $172.50–$172.50 | — | 1 |
| 2030 | $43.7B | +3.8% | $256.00 | $256.00–$256.00 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| +0.78% |
| $114.9B |
| — |
| 4694.TBML, Inc. | $3640.00 | +0.69% | $136.4B | — |
| 4974.TTakara Bio Inc. | $1144.00 | +0.09% | $137.8B | — |
Source: Financial Modeling Prep · peers by sector/industry